{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:49:32Z","timestamp":1790419772904,"version":"4.1.0"},"reference-count":32,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,1,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Thrombosis is a major cause of mortality in patients with myeloproliferative neoplasms (MPNs), though there is currently little to offer patients with MPN beyond aspirin and cytoreductive therapies such as hydroxyurea for primary prevention. Thrombogenesis in MPN involves multiple cellular mechanisms, including platelet activation and neutrophil-extracellular trap formation; therefore, an antithrombotic agent that targets one or more of these processes would be of therapeutic benefit in MPN. Here, we treated the JAK2V617F knockin mouse model of polycythemia vera with N-acetylcysteine (NAC), a sulfhydryl-containing compound with broad effects on glutathione replenishment, free radical scavenging, and reducing disulfide bonds, to investigate its antithrombotic effects in the context of MPN. Strikingly, NAC treatment extended the lifespan of JAK2V617F mice without impacting blood counts or splenomegaly. Using an acute pulmonary thrombosis model in vivo, we found that NAC reduced thrombus formation to a similar extent as the irreversible platelet inhibitor aspirin. In vitro analysis of platelet activation revealed that NAC reduced thrombin-induced platelet-leukocyte aggregate formation in JAK2V617F mice. Furthermore, NAC reduced neutrophil extracellular trap formation in primary human neutrophils from patients with MPN as well as healthy controls. These results provide evidence that N-acetylcysteine inhibits thrombosis in JAK2V617F mice and provide a pre-clinical rationale for investigating NAC as a therapeutic to reduce thrombotic risk in MPN.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019000967","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T12:12:08Z","timestamp":1579867928000},"page":"312-321","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":61,"title":["N-acetylcysteine inhibits thrombosis in a murine model of myeloproliferative neoplasm"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1844-7922","authenticated-orcid":false,"given":"Brianna M.","family":"Craver","sequence":"first","affiliation":[{"name":"Department of Biological Chemistry,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gajalakshmi","family":"Ramanathan","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summer","family":"Hoang","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura F.","family":"Mendez Luque","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1670-1939","authenticated-orcid":false,"given":"Stefan","family":"Brooks","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3525-3916","authenticated-orcid":false,"given":"Hew Yeng","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3701-6079","authenticated-orcid":false,"given":"Angela G.","family":"Fleischman","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry,"},{"name":"Division of Hematology\/Oncology, Department of Medicine, and"},{"name":"Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,1,24]]},"reference":[{"key":"2020012411394876500_B1","unstructured":"National Comprehensive Cancer Center Network\n          . Myeloproliferative Neoplasm Guidelines, 2019. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/mpn.pdf."},{"issue":"2","key":"2020012411394876500_B2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJMoa035572","article-title":"Efficacy and safety of low-dose aspirin in polycythemia vera","volume":"350","author":"Landolfi","year":"2004","journal-title":"N Engl J Med"},{"issue":"8","key":"2020012411394876500_B3","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1182\/blood-2010-01-263319","article-title":"Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia","volume":"116","author":"Alvarez-Larr\u00e1n","year":"2010","journal-title":"Blood"},{"key":"2020012411394876500_B4","doi-asserted-by":"publisher","first-page":"JCO2018788414","DOI":"10.1200\/JCO.2018.78.8414.","article-title":"Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features","author":"Godfrey","year":"2018","journal-title":"J. Clin. Oncol"},{"issue":"9464","key":"2020012411394876500_B5","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"issue":"7037","key":"2020012411394876500_B6","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"issue":"17","key":"2020012411394876500_B7","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"2020012411394876500_B8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"issue":"24","key":"2020012411394876500_B9","doi-asserted-by":"crossref","first-page":"22788","DOI":"10.1074\/jbc.C500138200","article-title":"Identification of an acquired JAK2 mutation in polycythemia vera","volume":"280","author":"Zhao","year":"2005","journal-title":"J Biol Chem"},{"issue":"3","key":"2020012411394876500_B10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1242\/dmm.006817","article-title":"Mouse models of myeloproliferative neoplasms: JAK of all grades","volume":"4","author":"Li","year":"2011","journal-title":"Dis Model Mech"},{"issue":"6","key":"2020012411394876500_B11","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ccr.2010.05.015","article-title":"Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells","volume":"17","author":"Mullally","year":"2010","journal-title":"Cancer Cell"},{"issue":"436","key":"2020012411394876500_B12","doi-asserted-by":"crossref","first-page":"eaan8292","DOI":"10.1126\/scitranslmed.aan8292","article-title":"Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms","volume":"10","author":"Wolach","year":"2018","journal-title":"Sci Transl Med"},{"issue":"7","key":"2020012411394876500_B13","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1182\/blood-2012-04-424911","article-title":"Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort","volume":"120","author":"Campbell","year":"2012","journal-title":"Blood"},{"issue":"16","key":"2020012411394876500_B14","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1200\/JCO.2007.15.3569","article-title":"Leukocytosis and risk stratification assessment in essential thrombocythemia","volume":"26","author":"Carobbio","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"2020012411394876500_B15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1034\/j.1600-0609.2001.00359.x","article-title":"Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count","volume":"66","author":"Jensen","year":"2001","journal-title":"Eur J Haematol"},{"issue":"3","key":"2020012411394876500_B16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.niox.2010.01.001","article-title":"Nitric oxide donors release extracellular traps from human neutrophils by augmenting free radical generation","volume":"22","author":"Patel","year":"2010","journal-title":"Nitric Oxide"},{"issue":"7","key":"2020012411394876500_B17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCULATIONAHA.117.027290","article-title":"Potent thrombolytic effect of N-acetylcysteine on arterial thrombi","volume":"136","author":"Martinez de Lizarrondo","year":"2017","journal-title":"Circulation"},{"key":"2020012411394876500_B18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.redox.2017.09.005","article-title":"N-acetylcysteine attenuates systemic platelet activation and cerebral vessel thrombosis in diabetes","volume":"14","author":"Wang","year":"2018","journal-title":"Redox Biol"},{"key":"2020012411394876500_B19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/1319-2442.124489","article-title":"The effect of treatment with N-acetylcysteine on the serum levels of C-reactive protein and interleukin-6 in patients on hemodialysis","volume":"25","author":"Saddadi","year":"2014","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"1","key":"2020012411394876500_B20","doi-asserted-by":"crossref","first-page":"11142","DOI":"10.1038\/srep11142","article-title":"Pentamethylquercetin (PMQ) reduces thrombus formation by inhibiting platelet function","volume":"5","author":"Liang","year":"2015","journal-title":"Sci Rep"},{"issue":"4","key":"2020012411394876500_B21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nm1565","article-title":"Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood","volume":"13","author":"Clark","year":"2007","journal-title":"Nat Med"},{"issue":"7","key":"2020012411394876500_B22","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1172\/JCI61303","article-title":"Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury","volume":"122","author":"Caudrillier","year":"2012","journal-title":"J Clin Invest"},{"issue":"11","key":"2020012411394876500_B23","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/leu.2013.102","article-title":"A role for reactive oxygen species in JAK2 V617F myeloproliferative neoplasm progression","volume":"27","author":"Marty","year":"2013","journal-title":"Leukemia"},{"issue":"23","key":"2020012411394876500_B24","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1182\/blood-2013-06-501452","article-title":"JAK2V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemia","volume":"122","author":"Hobbs","year":"2013","journal-title":"Blood"},{"issue":"7","key":"2020012411394876500_B25","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1182\/blood-2013-10-530832","article-title":"Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm","volume":"124","author":"Lamrani","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2020012411394876500_B26","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1073\/pnas.1312148111","article-title":"JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms","volume":"111","author":"Etheridge","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020012411394876500_B27","doi-asserted-by":"crossref","first-page":"710239","DOI":"10.1155\/2013\/710239","article-title":"Flavonoids and 5-aminosalicylic acid inhibit the formation of neutrophil extracellular traps","volume":"2013","author":"Kirchner","year":"2013","journal-title":"Mediators Inflamm"},{"issue":"28","key":"2020012411394876500_B28","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1038\/s41388-019-0813-7","article-title":"Addiction to DUSP1 protects JAK2V617F-driven polycythemia vera progenitors against inflammatory stress and DNA damage, allowing chronic proliferation","volume":"38","author":"Stetka","year":"2019","journal-title":"Oncogene"},{"issue":"2","key":"2020012411394876500_B29","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1172\/JCI41062","article-title":"N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice","volume":"121","author":"Chen","year":"2011","journal-title":"J Clin Invest"},{"issue":"6","key":"2020012411394876500_B30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1159\/000340041","article-title":"N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats","volume":"84","author":"Li","year":"2012","journal-title":"Respiration"},{"issue":"11","key":"2020012411394876500_B31","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1182\/blood-2015-02-629667","article-title":"Lysyl oxidase is associated with increased thrombosis and platelet reactivity","volume":"127","author":"Matsuura","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2020012411394876500_B32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/2\/312\/1558413\/advancesadv2019000967.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/2\/312\/1558413\/advancesadv2019000967.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T12:12:16Z","timestamp":1579867936000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/2\/312\/431284\/Nacetylcysteine-inhibits-thrombosis-in-a-murine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,24]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019000967","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,24]]}}}